Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)

Hung-Ming WangPei-Jen LouMuh-Hwa YangTein-Hua ChenMing-Yu LienJin-Ching LinJo-Pai ChenWei-Chen LuHsueh-Ju LuTai-Lin HuangChia-Jui YenShang-Yin WuHui-Ching WangMeng-Che Hsieh2026-02-042026-02-042024-0110.1007/s11523-023-01028-7https://scholars.csmu.edu.tw/handle/123456789/4916[SDGs]SDG3Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)journal-article